Insulin aspart biosimilar - Gan&Lee Pharmaceuticals
Alternative Names: Aspart 30 injection; Fast-acting aspart injection; GL-ASP; Rapilin; Rapilin30Latest Information Update: 06 Feb 2024
At a glance
- Originator Gan&Lee Pharmaceuticals
- Class Antihyperglycaemics; Insulins; Pancreatic hormones; Peptides
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Type 1 diabetes mellitus
- Registered Diabetes mellitus